Search for: "Abbvie Inc"
Results 121 - 140
of 143
Sort by Relevance
|
Sort by Date
10 Jul 2014, 10:00 pm
Janssen Biotech, Inc. [read post]
10 Jul 2014, 9:59 pm
Janssen Biotech, Inc., the Federal Circuit affirmed judgments by the District Court for the District of Massachusetts in infringement and interference actions involving AbbVie Deutschland GmbH & Co., KG; AbbVie Bioresearch Center, Inc.; and AbbVie Biotechnology Ltd. [read post]
2 Jul 2014, 1:42 pm
Cox Fibernet Va., Inc., 602 F.3d 1325 (Fed. [read post]
1 Jul 2014, 6:16 am
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]
10 Jun 2014, 7:29 am
AndroGel Testosterone Therapy Lawsuits Consolidated The Judicial Panel on Multidistrict Litigation (JPML) issued an order on June 6th to consolidate testosterone therapy injury lawsuits involving Abbott Laboratories and Abbvie, Inc testosterone gels. [read post]
6 Jun 2014, 1:18 pm
Lyon claims that AbbVie, Inc. and Abbott Laboratories withheld important information from patients and doctors about the risk of heart attacks and other blood clot injuries from Androgel use. [read post]
18 Apr 2014, 9:23 am
Motion Filed to Consolidate AndroGel Testosterone Therapy Lawsuits On March 28th, plaintiffs filed a motion to consolidate all lawsuits against AndroGel, manufactured by AbbVie Inc and Abbott Laboratories, into one multidistrict litigation (MDL). [read post]
17 Apr 2014, 2:32 pm
This is 10 months after a substantially identical Black Box Warning was added to Depakote, Depacon, and Depakene -- also valproic acid medicines -- by AbbVie Inc. [read post]
1 Apr 2014, 1:44 pm
From this March 29, 2014 article, "Plaintiffs File Motion to Consolidate All Federal Lawsuits Linking AndroGel Testosterone Therapy to Heart Attacks, Strokes" (subscription required for full article), published by HarrisMartin: Plaintiffs in more than a dozen federal lawsuits accusing Abbott Laboratories and AbbVie Inc. of concealing cardiovascular risks associated with the testosterone replacement therapy AndroGel have filed a petition to have all similar cases around the country… [read post]
24 Mar 2014, 10:39 am
Big Pharma On the Move The largest Big Pharma companies that make and market Low T medical products are: Abbvie, Inc. [read post]
19 Mar 2014, 9:00 am
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
11 Mar 2014, 6:58 am
by Vall d’Hebron Research Institute (VHIR) A lawsuit was filed last month against Abbott Laboratories and AbbVie, Inc., which manufacture AndroGel, which claims that the heart risks associated with the treatment have been downplayed. [read post]
1 Mar 2014, 6:22 am
(“Plaintiff”), residing in Johnstown, Pennsylvania, by and through his undersigned counsel, hereby sues Defendants AbbVie Inc. and Abbott Laboratories, Inc. [read post]
25 Feb 2014, 10:41 pm
AndroGel was heavily promoted by Abbott Laboratories and AbbVie Inc., with the companies selling the product through testimony from retired professional athletes. [read post]
23 Feb 2014, 9:29 pm
AbbVie Inc. et al. v. [read post]
19 Feb 2014, 6:57 am
Companies that have qualified for the pilot are • AbbVie Inc. [read post]
13 Feb 2014, 8:36 am
The following products treat low testosterone:Androderm (Actavis) – patch applied to the skinAndroGel (AbbVie Inc.) [read post]
30 Aug 2013, 10:11 am
Amount Of These Valproate Medications For Seizures, Epilepsy, Bipolar Disorder, And Migraines Taken During First Trimester Of Pregnancy Is A Factor (Posted by Tom Lamb at DrugInjuryWatch.com)We have posted two articles about Depakote / Depakene / Depacon (valproate) related birth defects thus far in the summer of 2013: (1) Depakote Or Depakene Taken During Pregnancy May Cause Congenital Malformations Or Birth Defects Such As Neural Tube Defects Like Spina Bifida (May 31, 2013)(2) Depacon /… [read post]
12 Jul 2013, 2:00 pm
May 2013 Revised Depakote Drug Label Includes "Black-Box" And Warnings About These Congenital Malformations As Well As Decreased IQ Scores In Children (Posted by Tom Lamb at DrugInjuryWatch.com) As indicated below, in May 2013 there was a so-called "Black-Box" warning and several other significant label revisions about serious risks for children whose mother used the following anti-seizure medications during pregnancy which were added to the Prescribing Information by FDA and the drug company… [read post]
3 Jun 2013, 8:59 am
(“AbbVie”) as plaintiff in the action; (2) denying Roxane Laboratories, Inc. [read post]
